Literature DB >> 16038974

Increased CRF-like and NPY-like immunoreactivity in adult rats exposed to nicotine during adolescence: relation to anxiety-like and depressive-like behavior.

Craig J Slawecki1, Annika K Thorsell, Aram El Khoury, Aleksander A Mathé, Cindy L Ehlers.   

Abstract

OBJECTIVE: Recently, animal models have been developed that demonstrate that adolescent nicotine exposure produces neurobehavioral changes which persist into adulthood. This study further examined the impact of adolescent nicotine exposure on anxiety-like and depressive-like behavior, as well as on levels of corticotropin-releasing factor (CRF) and neuropeptide Y (NPY) in this model.
METHODS: Male adolescent rats (35-40 days old) were administered nicotine using Nicoderm CQ patches (Smith-Kline Beecham). Behavior in the elevated plus maze (EPM) and forced swim test (FST) was assessed 2-3 weeks after exposure ended. Brain levels of CRF and NPY were then assessed 5-6 weeks after behavioral tests were completed. In addition, blood and brain levels of nicotine resulting from nicotine treatment were examined.
RESULTS: After 5 days of exposure to 5 mg/kg/day nicotine, blood levels of nicotine averaged 66+/-5 ng/ml and brain nicotine levels averaged 52+/-4 ng/g. Rats exposed to nicotine displayed an anxiety-like profile in the EPM (i.e., decreased time spent in the open arms) and an antidepressant-like profile in the FST (i.e., less time spent immobile). Rats exposed to nicotine also had increased hypothalamic and frontal cortical CRF, increased hypothalamic and hippocampal NPY, and a decreased ratio of NPY to CRF in the amygdala.
CONCLUSIONS: This study demonstrates that adolescent nicotine exposure produces lasting increases in anxiety-like behavior and may reduce depressive-like behavior. These behavioral changes also occurred in concert with alterations in CRF and NPY systems. Thus, lasting neurobehavioral changes associated with adolescent nicotine exposure may be related to allostatic changes in stress peptide systems.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16038974     DOI: 10.1016/j.npep.2005.06.002

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  27 in total

1.  Chronic fluoxetine ameliorates adolescent chronic nicotine exposure-induced long-term adult deficits in trace conditioning.

Authors:  David A Connor; Thomas J Gould
Journal:  Neuropharmacology       Date:  2017-08-02       Impact factor: 5.250

2.  Smoking impacts on prefrontal attentional network function in young adult brains.

Authors:  Francesco Musso; Franziska Bettermann; Goran Vucurevic; Peter Stoeter; Andreas Konrad; Georg Winterer
Journal:  Psychopharmacology (Berl)       Date:  2006-08-26       Impact factor: 4.530

3.  Effects of a selective Y2R antagonist, JNJ-31020028, on nicotine abstinence-related social anxiety-like behavior, neuropeptide Y and corticotropin releasing factor mRNA levels in the novelty-seeking phenotype.

Authors:  Cigdem Aydin; Ozge Oztan; Ceylan Isgor
Journal:  Behav Brain Res       Date:  2011-04-08       Impact factor: 3.332

Review 4.  Adolescent brain maturation and smoking: what we know and where we're headed.

Authors:  David M Lydon; Stephen J Wilson; Amanda Child; Charles F Geier
Journal:  Neurosci Biobehav Rev       Date:  2014-07-12       Impact factor: 8.989

Review 5.  Consequences of adolescent use of alcohol and other drugs: Studies using rodent models.

Authors:  Linda Patia Spear
Journal:  Neurosci Biobehav Rev       Date:  2016-07-30       Impact factor: 8.989

6.  Ethanol conditioned place preference and alterations in ΔFosB following adolescent nicotine administration differ in rats exhibiting high or low behavioral reactivity to a novel environment.

Authors:  Rex M Philpot; Melanie E Engberg; Lynn Wecker
Journal:  Behav Brain Res       Date:  2014-01-07       Impact factor: 3.332

Review 7.  Developmental toxicity of nicotine: A transdisciplinary synthesis and implications for emerging tobacco products.

Authors:  Lucinda J England; Kjersti Aagaard; Michele Bloch; Kevin Conway; Kelly Cosgrove; Rachel Grana; Thomas J Gould; Dorothy Hatsukami; Frances Jensen; Denise Kandel; Bruce Lanphear; Frances Leslie; James R Pauly; Jenae Neiderhiser; Mark Rubinstein; Theodore A Slotkin; Eliot Spindel; Laura Stroud; Lauren Wakschlag
Journal:  Neurosci Biobehav Rev       Date:  2016-11-24       Impact factor: 8.989

8.  Interaction of Cocaine- and Amphetamine-regulated Transcript and Neuropeptide Y on Behavior in the Central Nervous System.

Authors:  Aynur Müdüroğlu Kirmizibekmez; Murat Mengi; Ertan Yurdakoş
Journal:  Noro Psikiyatr Ars       Date:  2016-06-01       Impact factor: 1.339

9.  Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice.

Authors:  Weidong Li; Yu Zhou; J David Jentsch; Robert A M Brown; Xiaoli Tian; Dan Ehninger; William Hennah; Leena Peltonen; Jouko Lönnqvist; Matti O Huttunen; Jaakko Kaprio; Joshua T Trachtenberg; Alcino J Silva; Tyrone D Cannon
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-02       Impact factor: 11.205

10.  Age influences the effects of nicotine and monoamine oxidase inhibition on mood-related behaviors in rats.

Authors:  Anne-Sophie Villégier; Brittney Gallager; Jon Heston; James D Belluzzi; Frances M Leslie
Journal:  Psychopharmacology (Berl)       Date:  2010-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.